Allianz recognizes outstanding contributors with Unity Awards

Oliver Bäte Chairman of the Board of Management of Allianz SE (CEO) Allianz SE
Oliver Bäte Chairman of the Board of Management of Allianz SE (CEO) - Allianz SE
0Comments

Allianz Group has announced the recipients of its Allianz Unity Awards, recognizing individuals and teams who have demonstrated outstanding contributions within the organization. The company operates in nearly 70 countries, offering a range of insurance products and asset management services to both private and corporate clients.

Allianz is among the world’s largest insurers and asset managers. As of June 30, 2025, it managed approximately 749 billion euros on behalf of its insurance customers. In addition, its asset management divisions PIMCO and Allianz Global Investors are responsible for about 1.8 trillion euros in third-party assets.

The company emphasizes ecological and social criteria in its business operations and investment strategies, positioning itself as a leader in sustainability within the insurance sector according to the Dow Jones Sustainability Index. In 2024, Allianz reported a total business volume of 179.8 billion euros and an operating profit of 16.0 billion euros, achieved by over 156,000 employees.

No further details were provided regarding the specific winners or achievements recognized by this year’s Allianz Unity Awards.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.